Joanna Horobin - Net Worth and Insider Trading
Joanna Horobin Net Worth
The estimated net worth of Joanna Horobin is at least $46 dollars as of 2024-11-13. Joanna Horobin is the Chief Medical Officer of Aceragen Inc and owns about 120 shares of Aceragen Inc (ACGN) stock worth over $46. Joanna Horobin is also the Director of Kymera Therapeutics Inc and owns about 0 shares of Kymera Therapeutics Inc (KYMR) stock worth over $0. Details can be seen in Joanna Horobin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joanna Horobin has not made any transactions after 2024-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joanna Horobin
Joanna Horobin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joanna Horobin owns 5 companies in total, including Kymera Therapeutics Inc (KYMR) , Liquidia Corp (LQDA) , and Aceragen Inc (ACGN) among others .
Click here to see the complete history of Joanna Horobin’s form 4 insider trades.
Insider Ownership Summary of Joanna Horobin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KYMR | Kymera Therapeutics Inc | 2024-06-07 | director |
| LQDA | Liquidia Corp | 2021-03-24 | director |
| ACGN | Aceragen Inc | 2018-12-20 | Chief Medical Officer |
 | | 2012-10-23 | Chief Medical Officer |
| | 2021-03-30 | director |
Joanna Horobin Latest Holdings Summary
Joanna Horobin currently owns a total of 2 stocks. Among these stocks, Joanna Horobin owns 120 shares of Aceragen Inc (ACGN) as of December 20, 2018, with a value of $46 and a weighting of 100%. Joanna Horobin also owns 0 shares of Kymera Therapeutics Inc (KYMR) as of June 7, 2024, with a value of $0 and a weighting of 0%.
Latest Holdings of Joanna Horobin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACGN | Aceragen Inc | 2018-12-20 | 120 | 0.38 | 46 |
| KYMR | Kymera Therapeutics Inc | 2024-06-07 | 0 | 50.05 | 0 |
Holding Weightings of Joanna Horobin
Joanna Horobin Form 4 Trading Tracker
According to the SEC Form 4 filings, Joanna Horobin has made a total of 0 transactions in Aceragen Inc (ACGN) over the past 5 years. The most-recent trade in Aceragen Inc is the acquisition of 18 shares on December 20, 2018, which cost Joanna Horobin around $1,035.
According to the SEC Form 4 filings, Joanna Horobin has made a total of 1 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 8,500 shares on June 7, 2024, which brought Joanna Horobin around $280,415.
Insider Trading History of Joanna Horobin
- 1
Joanna Horobin Trading Performance
GuruFocus tracks the stock performance after each of Joanna Horobin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joanna Horobin is -3.37%. GuruFocus also compares Joanna Horobin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joanna Horobin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joanna Horobin's insider trading performs compared to the benchmark.
Performance of Joanna Horobin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.12 | | | | | |
| Relative Return to S&P 500(%) | -18.36 | | | | | |
Joanna Horobin Ownership Network
Ownership Network List of Joanna Horobin
Ownership Network Relation of Joanna Horobin
Joanna Horobin Owned Company Details
What does Kymera Therapeutics Inc do?
Who are the key executives at Kymera Therapeutics Inc?
Joanna Horobin is the director of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Medical Officer Jared Gollob , Chief Operating Officer Jeremy G Chadwick , and 10 percent owner Atlas Venture Fund X, L.p. .
Kymera Therapeutics Inc (KYMR) Insider Trades Summary
Over the past 18 months, Joanna Horobin made 1 insider transaction in Kymera Therapeutics Inc (KYMR) with a net sale of 8,500. Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .
In summary, during the past 3 months, insiders sold 18,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 1 shares, with a net sale of 18,499 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.
Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kymera Therapeutics Inc Insider Transactions
Joanna Horobin Mailing Address
Above is the net worth, insider trading, and ownership report for Joanna Horobin. You might contact Joanna Horobin via mailing address: 215 First Street, Suite 440, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
